These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15521370)

  • 21. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
    Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
    Meltzer EO; Garadi R; Laforce C; Chadwick SJ; Berger WE; Gross G; Edwards MR; Crenshaw K; Wall GM
    Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
    Berger WE; Godfrey JW; Slater AL
    Expert Opin Drug Deliv; 2007 Nov; 4(6):689-701. PubMed ID: 17970670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences and satisfaction with prescribed nasal steroids for allergic rhinitis.
    Kaliner MA
    Allergy Asthma Proc; 2001; 22(6 Suppl 1):S11-5. PubMed ID: 11775399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W; Prenner B; Corren J; Wheeler W
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal corticosteroids topical characteristics: side effects, formulation, and volume.
    Petty DA; Blaiss MS
    Am J Rhinol Allergy; 2013; 27(6):510-3. PubMed ID: 24274228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study.
    Mintz M; Garcia J; Diener P; Liao Y; Dupclay L; Georges G
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):255-61. PubMed ID: 14989396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Counseling patients about allergic rhinitis.
    Swanson KA
    J Am Pharm Assoc (Wash); 1996 May; NS36(5):300-7. PubMed ID: 8634937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and physician perspectives on the attributes of nasal allergy medications.
    Naclerio RM; Hadley JA; Stoloff S; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S11-7. PubMed ID: 18307839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reader's response to "comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?".
    Philpot EE
    MedGenMed; 2006 Apr; 8(2):3; author reply 2. PubMed ID: 16926742
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis.
    Navarro A; Valero A; Rosales MJ; Mullol J
    J Investig Allergol Clin Immunol; 2011; 21(5):363-9. PubMed ID: 21905499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes and adverse effect monitoring in allergic rhinitis.
    Juniper EF; Ståhl E; Doty RL; Simons FE; Allen DB; Howarth PH
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S390-413. PubMed ID: 15746880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patient preference survey on the lack of taste and odor of Nasonex nasal spray. Which impact on compliance to treatment?].
    Klossek JM; Serrano E; Dreyfus I; Mesbah K; Demoly P
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(1):35-41. PubMed ID: 18777767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way?
    Khan DA
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):506-8. PubMed ID: 16680918
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA; Berger W; Yang W; Cheema A; Silvey M; Wu W; Philpot E
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts and therapeutic strategies for allergic rhinitis in school-age children.
    Blaiss M
    Clin Ther; 2004 Nov; 26(11):1876-89. PubMed ID: 15639699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of nasal corticosteroids in the treatment of rhinitis.
    Meltzer EO
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):545-60. PubMed ID: 21737042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
    Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis.
    Long AA
    Clin Ther; 2007 Feb; 29(2):342-51. PubMed ID: 17472826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.